<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report" xml:lang="EN">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title>Emerging Infectious Diseases</journal-title>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18680661</article-id>
      <article-id pub-id-type="pmc">2600399</article-id>
      <article-id pub-id-type="publisher-id">08-0147</article-id>
      <article-id pub-id-type="doi">10.3201/eid1408.080147</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dispatch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Macrolide-Resistant <italic>Shigella sonnei</italic></article-title>
        <alt-title alt-title-type="running-head">Macrolide-Resistant <italic>Shigella sonnei</italic></alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Boumghar-Bourtchai</surname>
            <given-names>Leyla</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mariani-Kurkdjian</surname>
            <given-names>Patricia</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bingen</surname>
            <given-names>Edouard</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Filliol</surname>
            <given-names>Ingrid</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dhalluin</surname>
            <given-names>Anne</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff3">&#xA7;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ifrane</surname>
            <given-names>Shadia Ait</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weill</surname>
            <given-names>Fran&#xE7;ois-Xavier</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Leclercq</surname>
            <given-names>Roland</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Centre Hospitalier Universitaire C&#xF4;te de Nacre, Caen, France</aff>
        <aff id="aff2"><label>&#x2020;</label>H&#xF4;pital Robert Debr&#xE9;, Paris, France; &#x2021;Institut Pasteur, Paris</aff>
        <aff id="aff3"><label>&#xA7;</label>Universit&#xE9; de Caen, Caen, France</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Roland Leclercq, CHU de Caen, Service de Microbiologie, avenue C&#xF4;te de Nacre, 14033 Caen CEDEX, France; email: <email xlink:href="leclercq-r@chu-caen.fr">leclercq-r@chu-caen.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2008</year>
      </pub-date>
      <volume>14</volume>
      <issue>8</issue>
      <fpage>1297</fpage>
      <lpage>1299</lpage>
      <abstract>
        <p><italic>Shigella sonnei</italic> UCN59, isolated during an outbreak of <italic>S. sonnei</italic> in January 2007, was resistant to azithromycin (MIC 64 mg/L). The isolate contained a plasmid-borne <italic>mph</italic>(A) gene encoding a macrolide 2&#x2032;-phosphotransferase that inactivates macrolides. Emergence of the <italic>mph</italic>(A) gene in <italic>S. sonnei</italic> may limit usefulness of azithromycin for treatment of shigellosis.</p>
      </abstract>
      <kwd-group kwd-group-type="author" xml:lang="EN">
        <title>Keywords: </title>
        <kwd>Antibiotic resistance</kwd>
        <kwd>shigellosis</kwd>
        <kwd>surveillance</kwd>
        <kwd>outbreak</kwd>
        <kwd>azithromycin</kwd>
        <kwd>dispatch</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>Shigellosis remains a common gastrointestinal disease in developing and industrialized countries. It occurs mostly in children &lt;5 years of age; <italic>Shigella sonnei</italic> is the most frequently isolated species (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>). Ampicillin and trimethoprim-sulfamethoxazole alleviate the dysenteric syndrome of shigellosis and reduce the infectious period. However, current resistance patterns limit the use of these drugs (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Although fluoroquinolones are an effective alternative for adults, they are not approved for shigellosis treatment in children &lt;18 years of age because of their potential toxicity (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Azithromycin, a macrolide, represents an attractive treatment option for several reasons. It has in vitro activity against most <italic>Shigella</italic> spp. isolates (<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>), can be given once a day, and attains high intracellular concentrations (<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>). Despite MICs from 2 to 8 mg/L for <italic>Shigella</italic> spp., sufficient concentrations of azithromycin in the colon may inhibit <italic>Shigella</italic> spp. growth (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). Azithromycin is recommended by the American Academy of Pediatrics for treatment of shigellosis in children, by the World Health Organization as a second-line treatment in adults, and, since June 2004, by the Agence Fran&#xE7;aise de S&#xE9;curit&#xE9; Sanitaire des Produits de Sant&#xE9; (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>; <ext-link ext-link-type="uri" xlink:href="http://www.agmed.sante.gouv.fr/htm/10/filcoprs/mp040601.pdf">www.agmed.sante.gouv.fr/htm/10/filcoprs/mp040601.pdf</ext-link>). In 1996, 2002, 2003, and 2007, outbreaks of shigellosis caused by <italic>S. sonnei</italic> resistant to ampicillin and trimethoprim-sulfamethoxazole occurred in children in northern Paris. The outbreaks occurred in religious schools, similar to cyclic outbreaks in US Jewish schools related to secondary transmission (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>,<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>).We report an outbreak of shigellosis in and around Paris, France, in which azithromycin failure was related to emergence of plasmid-mediated resistance to macrolides.</p>
    <sec sec-type="other1">
      <title>The Study</title>
      <p>On January 24, 2007, <italic>S. sonnei</italic> strain UCN59 was isolated from a 4-year-old girl admitted to Robert Debr&#xE9; Hospital, Paris, for bloody diarrhea and fever. The strain was resistant to ampicillin, trimethoprim, sulfonamides, and cotrimoxazole but susceptible to quinolones, third-generation cephalosporins, and doxycycline according to the disk-diffusion technique. MICs of macrolides were markedly increased for <italic>S. sonnei</italic> UCN59 compared with those for a susceptible control <italic>S. sonnei</italic> UCN62 (<xref ref-type="table" rid="T1">Table</xref>). From January to April 23, 2007, a total of 50 cases of laboratory-confirmed shigellosis were identified. Isolates included, in addition to UCN59, 31 <italic>S. sonnei</italic> that had an azithromycin MIC <underline>&gt;</underline>64 mg/L from 31 children &lt;15 years of age, who had each been prescribed azithromycin for diarrhea. All patients lived in the Paris area and attended 8 religious schools.</p>
      <table-wrap id="T1" position="float">
        <label>Table</label>
        <caption>
          <title>Macrolide susceptibility of outbreak and control <italic>Shigella</italic> isolates and <italic>Escherichia coli</italic> constructs</title>
        </caption>
        <table frame="hsides" rules="groups">
          <col width="193" span="1"/>
          <col width="70" span="1"/>
          <col width="76" span="1"/>
          <col width="70" span="1"/>
          <col width="72" span="1"/>
          <thead>
            <tr>
              <th rowspan="2" valign="bottom" align="left" scope="col" colspan="1">Strain</th>
              <th valign="bottom" colspan="4" align="center" scope="colgroup" rowspan="1">MIC, mg/L<hr/></th>
            </tr>
            <tr>
              <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">Erythromycin</th>
              <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Clarithromycin</th>
              <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Azithromycin</th>
              <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Telithromycin</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Shigella sonnei</italic> UCN 62</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>S. sonnei</italic> UCN 59</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1,024</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1,024</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
              <td valign="top" align="center" rowspan="1" colspan="1">64</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>Escherichia coli</italic> K12 AG100A</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">2</td>
              <td valign="top" align="center" rowspan="1" colspan="1">1</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>E. coli</italic> K12 AG100A/pUV21</td>
              <td valign="top" align="center" rowspan="1" colspan="1">512</td>
              <td valign="top" align="center" rowspan="1" colspan="1">512</td>
              <td valign="top" align="center" rowspan="1" colspan="1">8</td>
              <td valign="top" align="center" rowspan="1" colspan="1">32</td>
            </tr>
            <tr>
              <td valign="top" align="left" scope="row" rowspan="1" colspan="1"><italic>E. coli</italic> K12 AG100A/pUC18&#x3A9;<italic>mph</italic>(A)</td>
              <td valign="top" align="center" rowspan="1" colspan="1">&gt;1,024</td>
              <td valign="top" align="center" rowspan="1" colspan="1">512</td>
              <td valign="top" align="center" rowspan="1" colspan="1">128</td>
              <td valign="top" align="center" rowspan="1" colspan="1">512</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Typing by pulsed-field gel electrophoresis (PFGE) and repetitive sequence&#x2013;based PCR (rep-PCR) by using the automated DiversiLab system (bioM&#xE9;rieux, La-Balme-les-Grottes, France) (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>) was performed on the 32 azithromycin-resistant and on 11 azithromycin-susceptible (MIC &lt;16 mg/L) sporadic or outbreak isolates obtained during 1996&#x2013;2007 in the Paris area. Five different PFGE patterns were obtained by using the enzyme <italic>Bln</italic>I. All the 2007 outbreak isolates, including the 32 azithromycin-resistant isolates and 2 azithromycin-susceptible isolates, were clustered into a single profile, profile 1 (<xref ref-type="fig" rid="F1">Figure 1</xref>). The presence of azithromycin-susceptible isolates with profile 1 was detected among the 1996 and 2002&#x2013;2006 outbreak isolates (data not shown), showing the persistence of this clonal type over 10 years in this area of Paris. Other isolates displayed PFGE types 2 to 5. Low diversity of PFGE profiles was consistent with isolation of strains in the same area and for most of them from the same community. Four different patterns with &lt;97% similarity were distinguished by rep-PCR (<xref ref-type="fig" rid="F2">Figure 2</xref>). Again, all the 2007 azithromycin-resistant isolates were clustered; however, they could be distinguished from the 2007 azithromycin-susceptible isolates. In contrast to PFGE findings, rep-PCR showed that isolates representative of the 1996, 2002, and 2003 outbreaks were genetically related.</p>
      <fig id="F1" fig-type="figure" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Pulsed-field gel electrophoresis&#x2013;generated dendrogram for 43 <italic>Shigella sonnei</italic> isolates obtained from sporadic or outbreak cases during 1996&#x2013;2007 in the Paris area. Profile 1) representative isolates from the 2007 outbreak, including 32 isolates with azithromycin MIC &gt;256 mg/L by Etest and 2 isolates with azithromycin MIC &lt;16 mg/L. Profile 2) 6 representative isolates from sporadic cases (2003&#x2013;2006) with azithromycin MIC &lt;16 mg/L. Profile 3) representative isolate Shi 03-3580 from 2003 outbreak with azithromycin MIC &lt;16 mg/L by Etest. Profile 4) representative isolate Shi 02-9633 from 2002 outbreak with azithromycin MIC &lt;16 mg/L by Etest. Profile 5) representative isolate Shi 96 1420 from 1996 outbreak with azithromycin MIC &lt;16 mg/L by Etest.</p>
        </caption>
        <graphic xlink:href="08-0147-F1"/>
      </fig>
      <fig id="F2" fig-type="figure" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Repetitive sequence&#x2013;based, PCR&#x2013;generated dendrogram for 43 <italic>Shigella sonnei</italic> isolates obtained from sporadic or outbreak cases during 1996&#x2013;2007 in the Paris area. Isolates with <underline>&gt;</underline>97% similarity were considered to be closely genetically related. Profile 1) representative of the 32 isolates of the 2007outbreak with azithromycin (MIC &gt;256 mg/L by Etest) . Profile 2) 1 of 6 isolates from sporadic cases (2003&#x2013;2006) with azithromycin MIC &lt;16 mg/L. Profile 3) representative isolate Shi 03-3580 from 2003 outbreak with azithromycin MIC &lt;16 mg/L by Etest. Profile 4) representative isolate Shi 02-9633 from 2002 outbreak with azithromycin MIC &lt;16 mg/L by Etest. Profile 5) representative isolate Shi 96 1420 from 1996 outbreak with azithromycin MIC &lt;16 mg/L by Etest. Profile 6) isolate from 2007 with azithromycin MIC &lt;16 mg/L by Etest; another AZM S 2007 isolate had an identical profile. AZM, azithromycin; R, resistant; S, sensitive; Rep, repetitive sequence-based PCR.</p>
        </caption>
        <graphic xlink:href="08-0147-F2"/>
      </fig>
      <p>The <italic>mph</italic>(A) gene, which encodes a macrolide 2&#x2032;-phosphotransferase that inactivates macrolide antimicrobial drugs, was amplified from <italic>S. sonnei</italic> UCN59 DNA by PCR (<xref ref-type="bibr" rid="R11"><italic>11</italic></xref>). PCR was negative for the <italic>erm</italic>(A), <italic>erm</italic>(TR), <italic>erm</italic>(B), <italic>erm</italic>(C), and <italic>erm</italic>(X) methylase genes; the <italic>ere</italic>(A), <italic>ere</italic>(B) genes encoding esterases; the <italic>mph</italic>(B) gene encoding a phosphotransferase; and the efflux genes <italic>mef</italic>(A) and <italic>msr</italic>(A). Sequence of the genes that encode ribosomal structures composing the target of macrolides, <italic>rrl</italic>, <italic>rplD,</italic> and <italic>rplV</italic> genes in <italic>S. sonnei</italic> UCN59, did not display any mutation in the critical bases of resistance to macrolides.</p>
      <p>The genes conferring resistance to ampicillin and erythromycin were transferred en bloc by conjugation from <italic>S. sonnei</italic> UCN59 to a macrolide-susceptible mutant <italic>Escherichia coli</italic> AG100A at a frequency of &#x2248;10<sup>&#x2013;3</sup> per donor cell-forming unit after the mating period. A single plasmid was extracted from a transconjugant <italic>E. coli</italic> AG100A/pUV21. After restriction analysis, its size was estimated at &#x2248;90 kb. PCR experiments showed that this plasmid belonged to incompatibility group I (<xref ref-type="bibr" rid="R12"><italic>12</italic></xref>). MICs of macrolides for <italic>E. coli</italic> AG100A/pUV21 confirmed that this plasmid conferred cross-resistance to macrolides (<xref ref-type="table" rid="T1">Table</xref>).</p>
      <p><italic>Eco</italic>RI-restricted fragments of plasmid pUV21 were transferred to a nylon membrane and hybridized to an <italic>mph</italic>(A) probe. The <italic>mph</italic>(A) gene was borne by an &#x2248;20-kb <italic>Eco</italic>RI fragment, confirming that resistance to azithromycin was plasmid mediated.</p>
      <p>After plasmid digestion with <italic>Pst</italic>I enzyme, a DNA fragment that conferred resistance to erythromycin was cloned in plasmid pUC18 and introduced by transformation into <italic>E.</italic> <italic>coli</italic> AG100A to generate <italic>E. coli</italic> K12 AG100A/pUC18&#x3A9;<italic>mph</italic>(A). Sequence of the inserted DNA was determined. The fragment contained 4 open reading frames (ORFs) in the same orientation: <italic>mph</italic>(A), <italic>mrx</italic> that putatively encodes a membrane protein, <italic>mphR</italic>(A) that regulates the expression of <italic>mph</italic>(A), and an ORF of unknown function. This series of ORFs was flanked by a copy of IS<italic>26</italic> at the 5&#x2032; end and a copy of IS<italic>6100</italic> at the 3&#x2032; end. BLAST analysis (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/blast/Blast.cgi">www.ncbi.nlm.nih.gov/blast/Blast.cgi</ext-link>) showed that the nucleotide sequence was nearly identical to that of fragments of plasmid pU302L from <italic>Salmonella</italic> <italic>enterica</italic> serotype Typhimurium (C.Y. Chen et al., unpub. data, GenBank accession no. NC_006816), of <italic>Shigella flexneri</italic> transposon TnSF1 (J.H. Chen and J.Y. Chen, unpub. data, GenBank accession no. AF188331), and of plasmids pRSB101 and pSRB107 (<xref ref-type="bibr" rid="R13"><italic>13</italic></xref>,<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>).</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>Few data are available on azithromycin resistance in <italic>Shigella</italic> spp. A recent report from Bangladesh mentioned that 16% of <italic>Shigella</italic> isolates were resistant to azithromycin and that 62% had intermediate resistance according to the Clinical Laboratory Standards Institute breakpoints recommended for streptococci (<underline>&gt;</underline>1 mg/L, resistant; &lt;0.25 mg/L, susceptible) (<xref ref-type="bibr" rid="R15"><italic>15</italic></xref>). However, the MIC<sub>90</sub> (MIC at which 90% are susceptible) of 8 mg/L displayed by the microorganisms was within the normal range of MICs for this microorganism; no isolate had an azithromycin MIC &gt;24 mg/L, which suggests that none had acquired resistance to azithromycin. Surveillance for resistance to azithromycin in <italic>Shigella</italic> spp. requires specific breakpoints for this species (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>).</p>
      <p>The <italic>mph</italic>(A) gene has been detected in the sequence of transposon TnSF1 isolated from <italic>S. flexneri</italic> (J.H. Chen and J.Y. Chen JY, unpub. data, GenBank accession no. AF188331). The <italic>mph</italic>(A) gene was first reported in an <italic>E. coli</italic> isolate from Japan (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>). Since then, the gene has been found in <italic>Aeromonas hydrophila</italic>, <italic>Pseudomonas</italic> spp., <italic>Stenotrophomonas</italic> spp., and a variety of enterobacteria (listed at <ext-link ext-link-type="uri" xlink:href="http://faculty.washington.edu/marilynr/ermweb4.pdf">http://faculty.washington.edu/marilynr/ermweb4.pdf</ext-link>).</p>
      <p>Azithromycin was used to treat shigellosis in France only after the release of the French recommendations in 2004. Subsequent rapid emergence of azithromycin-resistant isolates may be a limitation for the use of macrolides in shigellosis. Because use of azithromycin is proposed for treatment of shigellosis, susceptibility of the isolates to azithromycin should be routinely tested.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Boumghar-Bourtchai L, Mariani-Kurkdjian P, Bingen E, Filliol I, Dhalluin A, Ait Ifrane S, et al. Macrolide-resistant <italic>Shigella sonnei.</italic> Emerg Infect Dis [serial on the Internet]. 2008 Aug [<italic>date cited</italic>]. Available from <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/EID/content/14/8/1297.htm">http://www.cdc.gov/EID/content/14/8/1297.htm</ext-link></p>
      </fn>
    </fn-group>
    <bio>
      <p>Dr Boumghar-Bourtchai is pursuing a PhD degree at the University of Caen; she completed this work as part of her PhD program. Her main research interest is emergence of unusual mechanisms of resistance to macrolides in various bacteria, such as <italic>S. sonnei, Turicella otitidis,</italic> and other gram-positive organisms.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <citation citation-type="journal"><string-name><surname>Mead</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Slutsker</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dietz</surname> <given-names>V</given-names></string-name>, <string-name><surname>McCaig</surname> <given-names>LF</given-names></string-name>, <string-name><surname>Bresee</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Shapiro</surname> <given-names>C</given-names></string-name>, <etal/><article-title>Food-related illness and death in the United States.</article-title><source>Emerg Infect Dis</source> <year>1999</year>;<volume>5</volume>:<fpage>607</fpage>&#x2013;<lpage>25</lpage><pub-id pub-id-type="pmid">10511517</pub-id></citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <citation citation-type="journal"><collab>Centers for Disease Control and Prevention</collab> <article-title>Outbreaks of multidrug-resistant <italic>Shigella sonnei</italic> gastroenteritis associated with day care centers&#x2014;Kansas, Kentucky, and Missouri, 2005.</article-title><source>MMWR Morb Mortal Wkly Rep</source> <year>2006</year>;<volume>55</volume>:<fpage>1068</fpage>&#x2013;<lpage>71</lpage><pub-id pub-id-type="pmid">17021592</pub-id></citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <citation citation-type="journal"><string-name><surname>Jain</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Gupta</surname> <given-names>A</given-names></string-name>, <string-name><surname>Glanz</surname> <given-names>B</given-names></string-name>, <string-name><surname>Dick</surname> <given-names>J</given-names></string-name>, <string-name><surname>Siberry</surname> <given-names>GK</given-names></string-name> <article-title>Antimicrobial-resistant <italic>Shigella sonnei</italic>: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility.</article-title><source>Pediatr Infect Dis J</source> <year>2005</year>;<volume>24</volume>:<fpage>494</fpage>&#x2013;<lpage>7</lpage> <pub-id pub-id-type="doi">10.1097/01.inf.0000164707.13624.a7</pub-id><pub-id pub-id-type="pmid">15933557</pub-id></citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <citation citation-type="journal"><string-name><surname>Gordillo</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>KV</given-names></string-name>, <string-name><surname>Murray</surname> <given-names>B</given-names></string-name> <article-title>In vitro activity of azithromycin against bacterial enteric pathogens.</article-title><source>Antimicrob Agents Chemother</source> <year>1993</year>;<volume>37</volume>:<fpage>1203</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">8390813</pub-id></citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <citation citation-type="journal"><string-name><surname>Gladue</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Bright</surname> <given-names>GM</given-names></string-name>, <string-name><surname>Isaacson</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Newborg</surname> <given-names>MF</given-names></string-name> <article-title>In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.</article-title><source>Antimicrob Agents Chemother</source> <year>1989</year>;<volume>33</volume>:<fpage>277</fpage>&#x2013;<lpage>82</lpage><pub-id pub-id-type="pmid">2543276</pub-id></citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <citation citation-type="journal"><string-name><surname>Khan</surname> <given-names>WA</given-names></string-name>, <string-name><surname>Seas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dhar</surname> <given-names>U</given-names></string-name>, <string-name><surname>Salam</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Bennish</surname> <given-names>ML</given-names></string-name> <article-title>Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.</article-title><source>Ann Intern Med</source> <year>1997</year>;<volume>126</volume>:<fpage>697</fpage>&#x2013;<lpage>703</lpage><pub-id pub-id-type="pmid">9139555</pub-id></citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <citation citation-type="web"><collab>World Health Organization</collab> Guidelines for the control of shigellosis, including epidemics due to <italic>Shigella dysenteriae</italic> type 1 [cited 2008 Apr 1]. Available from <ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2005/9241592330.pdf">http://whqlibdoc.who.int/publications/2005/9241592330.pdf</ext-link></citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <citation citation-type="journal"><string-name><surname>Garrett</surname> <given-names>V</given-names></string-name>, <string-name><surname>Bornschlegel</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lange</surname> <given-names>D</given-names></string-name>, <string-name><surname>Reddy</surname> <given-names>V</given-names></string-name>, <string-name><surname>Kornstein</surname> <given-names>L</given-names></string-name>, <string-name><surname>Komblum</surname> <given-names>J</given-names></string-name>, <etal/><article-title>A recurring outbreak of <italic>Shigella sonnei</italic> among traditionally observant Jewish children in New York City: the risks of daycare and household transmission.</article-title><source>Epidemiol Infect</source> <year>2006</year>;<volume>134</volume>:<fpage>1231</fpage>&#x2013;<lpage>6</lpage> <pub-id pub-id-type="doi">10.1017/S0950268806006182</pub-id><pub-id pub-id-type="pmid">16623986</pub-id></citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <citation citation-type="journal"><string-name><surname>Sobel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cameron</surname> <given-names>DN</given-names></string-name>, <string-name><surname>Ismail</surname> <given-names>J</given-names></string-name>, <string-name><surname>Strockbine</surname> <given-names>N</given-names></string-name>, <string-name><surname>Williams</surname> <given-names>M</given-names></string-name>, <string-name><surname>Diaz</surname> <given-names>PS</given-names></string-name>, <etal/><article-title>A prolonged outbreak of <italic>Shigella sonnei</italic> infections in traditionally observant Jewish communities in North America caused by a molecularly distinct bacterial subtype.</article-title><source>J Infect Dis</source> <year>1998</year>;<volume>177</volume>:<fpage>1405</fpage>&#x2013;<lpage>9</lpage><pub-id pub-id-type="pmid">9593035</pub-id></citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <citation citation-type="journal"><string-name><surname>Healy</surname> <given-names>M</given-names></string-name>, <string-name><surname>Huong</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bittner</surname> <given-names>T</given-names></string-name>, <string-name><surname>Lising</surname> <given-names>M</given-names></string-name>, <string-name><surname>Frye</surname> <given-names>S</given-names></string-name> <article-title>Microbial DNA typing by automated repetitive-sequence-based PCR.</article-title><source>J Clin Microbiol</source> <year>2005</year>;<volume>43</volume>:<fpage>199</fpage>&#x2013;<lpage>207</lpage> <pub-id pub-id-type="doi">10.1128/JCM.43.1.199-207.2005</pub-id><pub-id pub-id-type="pmid">15634972</pub-id></citation>
      </ref>
      <ref id="R11">
        <label>11. </label>
        <citation citation-type="journal"><string-name><surname>Noguchi</surname> <given-names>N</given-names></string-name>, <string-name><surname>Emura</surname> <given-names>A</given-names></string-name>, <string-name><surname>Matsuyama</surname> <given-names>H</given-names></string-name>, <string-name><surname>O'Hara</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sasatsu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kono</surname> <given-names>M</given-names></string-name> <article-title>Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2&#x2032;-phosphotransferase I in <italic>Escherichia coli.</italic></article-title><source>Antimicrob Agents Chemother</source> <year>1995</year>;<volume>39</volume>:<fpage>2359</fpage>&#x2013;<lpage>63</lpage><pub-id pub-id-type="pmid">8619599</pub-id></citation>
      </ref>
      <ref id="R12">
        <label>12. </label>
        <citation citation-type="journal"><string-name><surname>Carattoli</surname> <given-names>A</given-names></string-name>, <string-name><surname>Bertini</surname> <given-names>A</given-names></string-name>, <string-name><surname>Villa</surname> <given-names>L</given-names></string-name>, <string-name><surname>Falbo</surname> <given-names>V</given-names></string-name>, <string-name><surname>Hopkins</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Threlfall</surname> <given-names>EJ</given-names></string-name> <article-title>Identification of plasmids by PCR-based replicon typing.</article-title><source>J Microbiol Methods</source> <year>2005</year>;<volume>63</volume>:<fpage>219</fpage>&#x2013;<lpage>28</lpage> <pub-id pub-id-type="doi">10.1016/j.mimet.2005.03.018</pub-id><pub-id pub-id-type="pmid">15935499</pub-id></citation>
      </ref>
      <ref id="R13">
        <label>13. </label>
        <citation citation-type="journal"><string-name><surname>Szczepanowski</surname> <given-names>R</given-names></string-name>, <string-name><surname>Krahn</surname> <given-names>I</given-names></string-name>, <string-name><surname>Linke</surname> <given-names>B</given-names></string-name>, <string-name><surname>Goesmann</surname> <given-names>A</given-names></string-name>, <string-name><surname>P&#xFC;hler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schl&#xFC;ter</surname> <given-names>A</given-names></string-name> <article-title>Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system.</article-title><source>Microbiology</source> <year>2004</year>;<volume>150</volume>:<fpage>3613</fpage>&#x2013;<lpage>30</lpage> <pub-id pub-id-type="doi">10.1099/mic.0.27317-0</pub-id><pub-id pub-id-type="pmid">15528650</pub-id></citation>
      </ref>
      <ref id="R14">
        <label>14. </label>
        <citation citation-type="journal"><string-name><surname>Szczepanowski</surname> <given-names>R</given-names></string-name>, <string-name><surname>Braun</surname> <given-names>S</given-names></string-name>, <string-name><surname>Riedel</surname> <given-names>V</given-names></string-name>, <string-name><surname>Schneiker</surname> <given-names>S</given-names></string-name>, <string-name><surname>Krahn</surname> <given-names>I</given-names></string-name>, <string-name><surname>P&#xFC;hler</surname> <given-names>A</given-names></string-name>, <etal/><article-title>The 120 592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions.</article-title><source>Microbiology</source> <year>2005</year>;<volume>151</volume>:<fpage>1095</fpage>&#x2013;<lpage>111</lpage> <pub-id pub-id-type="doi">10.1099/mic.0.27773-0</pub-id><pub-id pub-id-type="pmid">15817778</pub-id></citation>
      </ref>
      <ref id="R15">
        <label>15. </label>
        <citation citation-type="journal"><string-name><surname>Rahman</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shoma</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rashid</surname> <given-names>H</given-names></string-name>, <string-name><surname>El Arifeen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Baqui</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Siddique</surname> <given-names>AK</given-names></string-name>, <etal/><article-title>Increasing spectrum in antimicrobial resistance of <italic>Shigella</italic> isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.</article-title><source>J Health Popul Nutr</source> <year>2007</year>;<volume>25</volume>:<fpage>158</fpage>&#x2013;<lpage>67</lpage><pub-id pub-id-type="pmid">17985817</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
